Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guanxin Danshen Dripping Pills is a Traditional Chinese Medicine (TCM) product widely used in China for the treatment of cardiovascular diseases, particularly coronary artery disease (CAD) and angina pectoris. The formulation typically includes extracts from *Salvia miltiorrhiza* (Danshen), *Panax notoginseng* (Sanqi), and *Dalbergia odorifera* (Jiangxiang). It is designed to promote blood circulation, resolve blood stasis, and regulate qi to alleviate pain. The dripping pill dosage form is a modern TCM preparation that enhances bioavailability and allows for rapid absorption, often used for both chronic management and acute relief of chest pain. Clinical studies have expanded its investigation into the treatment of CAD patients with comorbid psychological distress, such as depression and anxiety, exploring its potential systemic anti-inflammatory and neuroprotective effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Guanxin Danshen Dripping Pills.